Nereus Life Sciences LLC

Global Verification Network (GVN) is a full-service employment and tenant screening services provider based in Scituate, MA. Owned by TriHelix Investments, GVN offers background screening solutions for professional property managers, management companies, large corporations, independent rental owners, real estate agents, and applicants. With a focus on compliance and consumer privacy, GVN recently acquired key assets of MOCO, integrating their technology and personnel to enhance operational efficiencies and ensure legal compliance in today's regulatory environment. Through their proprietary software and commitment to protecting consumer rights, GVN aims to provide cost-effective and legally compliant screening services for clients in the employment and tenant screening industries.Generated from the website

Cardiovascular Engineering Inc is located at 1 Edgewater Drive, Suite 201 in Norwood, Massachusetts. The company specializes in advancements in cardiovascular technology and engineering solutions. Committed to innovation, Cardiovascular Engineering Inc focuses on delivering high-quality products and services that enhance cardiovascular health. Their expertise contributes to the development of critical solutions in the field of heart health and engineering. Generated from the website

Vedanta Biosciences, Inc., based in Cambridge, MA, is at the forefront of developing first-in-class Live Biotherapeutic Products (LBPs) to address serious gastrointestinal diseases through the strategic use of defined bacterial consortia. The company is focused on advancing innovative treatments for conditions such as inflammatory bowel disease and recurrent Clostridium difficile infections, with ongoing clinical trials to evaluate the efficacy and safety of its drug candidates. Committed to improving patient outcomes, Vedanta emphasizes the importance of gut health and the role of dysbiosis in gastrointestinal disorders. Through a robust scientific framework, the company leverages its expertise in immune response stimulation and microbial therapies to usher in a new era of gastrointestinal health management. Generated from the website